Pyxis Oncology, Inc.·4

Apr 2, 8:56 AM ET

Connealy Pamela Ann 4

4 · Pyxis Oncology, Inc. · Filed Apr 2, 2025

Insider Transaction Report

Form 4
Period: 2025-03-31
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-31$0.98/sh+414,163$405,880414,163 total
    Exercise: $0.98Exp: 2035-03-31Common Stock (414,163 underlying)
Footnotes (1)
  • [F1]The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 31, 2025 and the remainder vesting in 36 equal monthly installments thereafter subject to the reporting person's continued emmployment through the applicable vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4